January 27, 2015 8:53 AM ET


Company Overview of Molecular Templates, Inc.

Executive Profile

Randal D. Chase Ph.D.

Chief Executive Officer of ImmunoVaccine Technologies Inc. and President of ImmunoVaccine Technologies Inc., Immunotope, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 9 different industries.

See Board Relationships


Dr. Randal D. Chase, Ph.D. served as the Chief Executive Officer and President of ImmunoVaccine Technologies Inc (also known as ImmunoVaccine Inc). from 2006 to April 14, 2011 and also served as its Acting Chief Financial Officer. Dr. Chase served as the President of Global Mandate of Shire Biologics, a division of Shire Pharmaceuticals Plc from May 2001 to 2004. Dr. Chase held senior positions at several pharmaceutical and biotechnology companies, including a number ...

Corporate Headquarters

111 West Cooperative Way
Georgetown, Texas 78626

United States

Phone: 512-930-0304
Fax: 512-233-2709

Board Members Memberships

Former Chief Executive Officer, President and Director
Former Executive Chairman
Independent Non Executive Director, Member of Nominations Committee, Member of Audit Committee and Member of Remuneration Committee
Chairman and Member of Audit Committee
Former Director and Member of Audit Committee
Former Director, Chairman of Corporate Governance & Nominating Committee, Member of Audit Committee and Member of Compensation Committee
Former Chief Executive Officer and President
Chairman of the Board


University Of British Columbia
BS 1974
Bishop's University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Molecular Templates, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.